ZCI
LAB icon

Zevenbergen Capital Investments’s Standard BioTools LAB Stock Holding History

Zevenbergen Capital Investments’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-456,150
Closed -$11.2M – 83
2014
Q3 		$11.2M Sell
456,150
-116,850
-20% -$3.29M 0.48% 41
2014
Q2 		$16.8M Buy
573,000
+125,000
+28% +$4.01M 0.59% 41
2014
Q1 		$19.7M Buy
+448,000
New +$19.7M 0.71% 43

Other funds holding LAB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Zevenbergen Capital Investments's LAB Position: Q4 2014 in Review

Zevenbergen Capital Investments sold out of Standard BioTools (LAB) in Q4 2014, closing a stake of 456,150 shares — an estimated $11.2M sold.

Zevenbergen Capital Investments first reported a position in LAB in Q1 2014 and held it in 3 quarters. The position peaked at $19.7M in Q1 2014. 100 funds tracked by Wall St. Rank hold LAB as of Q4 2014.

  • Zevenbergen Capital Investments reported no remaining Standard BioTools position as of Q4 2014 after selling out during the quarter.
  • Zevenbergen Capital Investments sold 456,150 Standard BioTools shares in Q4 2014, an estimated $11.2M.
  • Zevenbergen Capital Investments first reported a position in Standard BioTools in Q1 2014 and held it in 3 quarters.
  • Zevenbergen Capital Investments's Standard BioTools position peaked at $19.7M in Q1 2014.
  • 100 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2014.

Based on Zevenbergen Capital Investments's 13F filing for Q4 2014, filed 12 Feb 2015.